Publication date: October 2026 Source: American Journal of Obstetrics and Gynecology, Volume 235, Issue 4 Author(s): Koji Matsuo, Matthew W. Lee, Emmeline L. Friedman, Hadi Erfani, Alexia J. Ouzounian, Shinya Matsuzaki, Lynda D. Roman
Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer. // American Journal of Obstetrics & Gynecology. – URL: https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all
Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer. American Journal of Obstetrics & Gynecology. https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all
“Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.” American Journal of Obstetrics & Gynecology.
@article{article116376,
title = {Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer},
journal = {American Journal of Obstetrics \& Gynecology},
url = {https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all}
}
ABSTRACT Introduction Postpartum hemorrhage (PPH) has significant short‐ and long‐term effects for women. Research typically focuses on women who experience severe bleeding. Little is known about women's understanding of their risk or...